American Vanguard Corporation’s (AVD) shares have gained 19% in the past three months. The company also outperformed the industry’s fall of 14.8% over the same time frame. It has also topped the S&P 500’s nearly 9.2% rise over the same period.Image Source: Zacks Investment ResearchLet’s take a look at the factors behind the stock’s price appreciation.What’s Driving American Vanguard?In the fourth quarter, American Vanguard saw a notable boost in revenues within its U.S. crop business. Revenues increased 11% ...

The Zacks Chemicals Specialty industry is expected to benefit from a demand rebound in key markets, as the unprecedented customer inventory destocking that plagued the industry for much of 2023 is nearing completion.Industry players like PPG Industries, Inc. (PPG) , Daqo New Energy Corp. (DQ) , Hawkins, Inc. (HWKN) and American Vanguard Corporation (AVD) are poised to benefit from improved demand. Strategic actions, including operating cost reductions, are also expected to help these companies navigate a st ...

One stock that might be an intriguing choice for investors right now is American Vanguard Corporation (AVD) . This is because this security in the Chemical - Specialty space is seeing solid earnings estimate revision activity, and is in great company from a Zacks Industry Rank perspective.This is important because, often times, a rising tide will lift all boats in an industry, as there can be broad trends taking place in a segment that are boosting securities across the board. This is arguably taking place ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Title of each class Trading Symbol(s) Name of each exchange on which registered Common Stock, $0.10 par value AVD New York Stock Exchange FORM 10-K ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For The Year Ended December 31, 2023 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For The Transition Period From To Commission file number 001-13795 AMERICA ...

Vanguard doesn't expect the Federal Reserve to cut interest rates this year, defying the view from Fed officials that the central bank remains on track to reduce rates three times in 2024.The Fed on Wednesday left interest rates unchanged for the fifth consecutive time, as expected, keeping its benchmark overnight borrowing rate in a range between 5.25%-5.5%.It also said it still expects three quarter-percentage-point cuts by the end of the year.The message fueled a market rally in both the U.S. and beyond. ...

The price-to-earnings (P/E) ratio is broadly considered the yardstick for evaluating the fair market value of a stock. It is preferred by many investors while handpicking stocks trading at attractive prices. However, even this universally used valuation multiple is not without its limitations.Although P/E is the most popular valuation metric, a more complicated multiple called EV-to-EBITDA works even better. Often considered a better alternative to P/E, it gives the true picture of a company’s valuation and ...

Exhibit 99.1 FOR IMMEDIATE RELEASE AMERICAN VANGUARD REPORTS FOURTH QUARTER & FULL YEAR 2023 RESULTS SETS $15MM ADJUSTED EBITDA GAIN AS TRANSFORMATION TARGET Newport Beach, CA – March 14, 2024 – American Vanguard Corporation (NYSE: AVD) today announced financial results for the fourth quarter and full year ended December 31, 2023. Fiscal 2023 Fourth Quarter Financial Highlights – versus Fiscal 2022 Fourth Quarter: • Net sales were $172.2 million in 2023, compared to $159.5 million in 2022 • Net income was $ ...

Core Insights - American Vanguard (AVD) is currently rated 2 (Buy) by Zacks and has a Value grade of A, indicating strong potential for value investors [2] - AVD's P/E ratio stands at 14.92, significantly lower than the industry average of 24.31, suggesting it may be undervalued [2] - The stock's Forward P/E has fluctuated between 7.12 and 37.83 over the past year, with a median of 15.05, indicating variability in market perception [2] - AVD's P/S ratio is 0.64, compared to the industry average of 1.73, reinforcing the notion of undervaluation based on revenue metrics [2] - The P/CF ratio for AVD is 10.21, lower than the industry average of 12.89, further supporting the argument that AVD is undervalued based on cash flow [3] - Over the past 52 weeks, AVD's P/CF has ranged from 8.13 to 14.09, with a median of 10.68, indicating stable cash flow performance [3] - Overall, AVD's strong earnings outlook and key valuation metrics suggest it is an impressive value stock at the moment [3]

American Vanguard Corporation (AVD) logged earnings of 25 cents per share in the fourth quarter of 2023 against earnings of 13 cents a year ago. It was in line with the Zacks Consensus Estimate of 25 cents.Revenues were $172.2 million for the reported quarter, up around 8% year over year. Revenues missed the Zacks Consensus Estimate of $172.7 million. In the fourth quarter, the company experienced a rebound following challenges such as global destocking within the distribution channel, oversupply of Chinese ...

Financial Data and Key Metrics Changes - For the full year 2023, overall sales declined by about 5% from $610 million to $579 million, primarily due to the unavailability of key products Aztec and Dacthal [16][17] - Gross profit decreased by about 7%, with gross margin percentage dropping from 32% to 31% year-over-year [17] - Net income for the year was approximately $7.5 million, or $0.26 per share, with most of this income generated in Q4 [19] Business Line Data and Key Metrics Changes - U.S. crop sales declined by 7% due to the unavailability of Aztec and Dacthal, while U.S. non-crop and international sales declined more modestly [16] - In Q4, sales increased by 8% compared to the prior year, attributed to improved supply chain conditions and reduced destocking [9][10] Market Data and Key Metrics Changes - The price of corn in the U.S. dropped nearly one-third since early last year, from $6.38 per bushel to about $4.25 per bushel, impacting the overall market conditions [11] - Demand for crop inputs remains stable despite declining commodity prices, with biological products gaining traction among growers [11][12] Company Strategy and Development Direction - The company is targeting a sales increase of 8% to 12% and adjusted EBITDA of $70 million to $80 million for 2024, aiming to enhance shareholder value [7][15] - A business transformation initiative is underway to improve operating leverage and move adjusted EBITDA to 15% of net sales by 2026, expected to generate an additional $15 million in annualized EBITDA [22][23] Management's Comments on Operating Environment and Future Outlook - Management expressed confidence in the stability of current market conditions and the company's ability to rebound from previous supply chain issues [8][10] - The outlook for 2024 is positive, with expectations of strong demand for key products like Aztec as the season unfolds [42] Other Important Information - The company plans to file its Form 10-K with the SEC for an extension due to ongoing documentation completion [4] - The company has dual-sourced the supply of raw materials for key products to ensure continuity and availability going forward [9] Q&A Session Summary Question: Update on SIMPAS adoption and future opportunities - Management indicated that approximately 240 to 250 SIMPAS systems are currently in play, with ongoing approvals and positive results from prescriptive applications [29][30] Question: Clarification on the transformation plan and KPIs - The additional $15 million in savings is expected to be realized on an annualized basis by 2026, with KPIs focusing on gross margin, EBITDA, and operational efficiencies [32][34] Question: Outlook for 2024 regarding key products - Management expects normalized demand for Aztec and Dacthal in 2024, with strong orders and no inventory build anticipated [42] Question: Impact of dicamba registration uncertainty - Management noted that the outcome of dicamba's regulatory status is uncertain, but they are ramping up their herbicide portfolio to capitalize on potential opportunities [49][50]